127 Results for "

MDA-MB-231cells

" in MedChemExpress (MCE) Product Catalog:
Products (127)

127 Results for "MDA-MB-231cells" in MCE Product Catalog:

44
44 Publications Verification
Cat. No.: HY-15518
CAS No.: 1005342-46-0
Purity:  99.91%
Target:  

IAP

Research Areas:  

Cancer

LCL161 is a IAP inhibitor which inhibits XIAP in HEK293 cell and cIAP1 in MDA-MB-231 cell with IC50s of 35 and 0.4 nM, respectively.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-112842
CAS No.: 2097938-73-1
Purity:  99.64%
Target:  

Ras CDK

Research Areas:  

Cancer

MBQ-167 is a dual Rac/Cdc42 inhibitor, with IC50s of 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-100753
CAS No.: 2059952-75-7
Purity:  96.28%
Target:  

STAT Apoptosis

Research Areas:  

Cancer

STAT3-IN-1 (compound 7d) is an excellent, selective and orally active STAT3 inhibitor, with IC50 values of 1.82 μM and 2.14 μM in HT29 and MDA-MB 231 cells, respectively. STAT3-IN-1 (compound 7d) induces tumor cells apoptosis .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-139665
CAS No.: 2230186-18-0
Purity:  98.91%
Research Areas:  

Cardiovascular Disease

VB124 is an orally active, potent, and selective MCT4 inhibitor. VB124 can specifically inhibit lactate efflux with IC50s of 8.6 nM and 19 nM for lactate import and export in MDA-MB-231 cells, respectively. VB124 is highly selective for MCT4 over MCT1. VB124 can be used for the research of cardiac hypertrophy, heart failure, and metabolism .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-13808
CAS No.: 1320288-19-4
Purity:  99.27%
Research Areas:  

Cancer

UNC 0631 is a potent histone methyltransferase G9a inhibitor with an IC50 of 4 nM. UNC 0631 potently reduces H3K9me2 levels in MDA-MB-231 cells with an IC50 of 25 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-146751
CAS No.: 2757804-89-8
Purity:  99.93%
Target:  

PI3K Akt mTOR Apoptosis

Research Areas:  

Cancer

PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15985
CAS No.: 1439934-41-4
Target:  

Akt

CTX-0294885 is a broad spectrum kinase inhibitor that can capture 235 kinases from MDA-MB-231 cells, and can capture all members of the AKT family. CTX-0294885 is a powerful reagent for analysis of kinome signaling networks that can be used for the research of diseases like inflammation, diabetes, and cancer .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15985A
CAS No.: 2319590-02-6
Target:  

Akt

CTX-0294885 hydrochloride is a broad spectrum kinase inhibitor that can capture 235 kinases from MDA-MB-231 cells, and can capture all members of the AKT family. CTX-0294885 hydrochloride is a powerful reagent for analysis of kinome signaling networks that can be used for the research of diseases like inflammation, diabetes, and cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-109523
CAS No.: 143201-11-0
Purity:  99.84%
Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent, well-tolerated and orally active HMG-CoA reductase inhibitor, with a Ki of 1.3 nM/L. Cerivastatin sodium reduces low-density lipoprotein cholesterol levels. Cerivastatin sodium also inhibits proliferation and invasiveness of MDA-MB-231 cells, mainly by RhoA inhibition, and has anti-cancer effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145652
CAS No.: 1393653-34-3
Purity:  99.86%
Synonyms: AMP-945
Narmafotinib (AMP-945) is an orally active inhibitor of the enzyme focal adhesion kinase (FAK, KD=0.21 nM). Narmafotinib inhibits autophosphorylation of 397Y-FAK in MDA-MB-231 cells with an IC50=7 nM and exhibits low general cellular toxicity (IC50=2.7 μM, MDA-MB-231 cells). Narmafotinib can be used for anti-cancer study .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13807
CAS No.: 1320288-17-2
Purity:  99.38%
Research Areas:  

Cancer

UNC0646 is a potent and selective histone methyltransferase G9a inhibitor with an IC50 of 6 nM. UNC0646 is also a potent GLP inhibitor (IC50 <15 nM) and highly selective for G9a/GLP over SETD7, SUV39H2, SETD8 and PRMT3. UNC0646 reduces H3K9me2 levels in MDA-MB-231 cells with an IC50 of 26 nM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-170620
Target:  

PROTACs PARP

Research Areas:  

Cancer

PARP1 PROTAC 180055 is a selective PARP1 PROTAC degrader (DC50 in T47D and MDA-MB-231 cell lines is 180 nM and 240 nM, respectively). PARP1 PROTAC 180055 promotes ubiquitination and degradation of PARP1 as well as inhibits PARP1 enzyme activity without a noticeable DNA trapping effect. PARP1 PROTAC 180055 inhibits tumors carrying BRCA mutations with a minor impact on the growth of normal cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100353
CAS No.: 74713-60-3
Purity:  99.82%
Synonyms: N-Lauroyl-D-erythro-sphingosine; N-Laurylsphingosine
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease Cancer

C12-Ceramide (N-Lauroyl-D-erythro-sphingosine), a naturally occurring ceramide, is formed by hydrolysis of C12 sphingomyelin. C12-Ceramide can enhance the Doxorubicin toxicity in MDA-MB-231 cells. C12-Ceramide also can be used to diagnose types A and B Niemann-Pick disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-155663
CAS No.: 2922824-09-5
Purity:  99.90%
Research Areas:  

Cancer

GPX4-IN-5 is a covalent inhibitor of GPX4 (IC50: 0.12 μM). GPX4-IN-5 can induce ferroptosis and has anti-tumor effects. GPX4-IN-5 can be used in the study of triple-negative breast cancer (TNBC) .
loading...
    loading...
Cat. No.: HY-108317
CAS No.: 1073529-41-5
Purity:  99.6%
Target:  

Phosphatase

Research Areas:  

Cancer

ABL127 is a selective and covalent inhibitor of protein methylesterase 1 (PME-1) with IC50s of 6.4 nM and 4.2 nM in HEK293T and MDA-MB-231 cells, respectively.
loading...
    loading...
Cat. No.: HY-173496
CAS No.: 192876-13-4
Research Areas:  

Cancer

ST6GAL1-IN-1 is an orally active selective ST6GAL1 inhibitor (IC50 = 20 μM). ST6GAL1-IN-1 exhibits high antimetastatic potential, effectively inhibiting the migration of MDA-MB-231 cells at noncytotoxic concentrations. ST6GAL1-IN-1 can disrupt integrin sialylation in MDA-MB-231 cells. ST6GAL1-IN-1 inhibits tumor angiogenesis and cancer metastasis via the Integrin/VEGFR2-mediated signaling pathway. ST6GAL1-IN-1 effectively suppresses both tumor growth and cancer metastasis on the MDA-MB-231 xenograft model. ST6GAL1-IN-1 can be used for the study of Triple-negative breast cancer (TNBC) .
loading...
    loading...
Cat. No.: HY-13808R
CAS No.: 1320288-19-4
Research Areas:  

Cancer

UNC 0631 (Standard) is the analytical standard of UNC 0631. This product is intended for research and analytical applications. UNC 0631 is a potent histone methyltransferase G9a inhibitor with an IC50 of 4 nM. UNC 0631 potently reduces H3K9me2 levels in MDA-MB-231 cells with an IC50 of 25 nM .
loading...
    loading...
Cat. No.: HY-146324
CAS No.: 2458170-54-0
Purity:  98.64%
Target:  

PROTACs Apoptosis CaMK

Research Areas:  

Cancer

PROTAC eEF2K degrader-1 (Compound 11l) is an eEF2K-Targeting PROTAC small molecule that induces apoptosis in MDA-MB-231 cells. PROTAC eEF2K degrader-1 mediates eEF2K degradation .
loading...
    loading...
Cat. No.: HY-114979
CAS No.: 25683-07-2
Purity:  99.90%
Research Areas:  

Infection Cancer

Pyoluteorin is an antibiotic that inhibits Oomycete fungi, including the plant pathogen Pythium ultimum, and suppresses plant diseases caused by this fungus . Pyoluteorin induces human triple-negative breast cancer MDA-MB-231 cells apoptosis in vitro. Pyoluteorin can be used for the research of human triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-N6990
CAS No.: 29388-33-8
Anhydrosecoisolariciresinol is from the flower of Wedelia biflora, has anti-tumor activities . Anhydrosecoisolariciresinol decreases the growth of human breast cancer MCF-7 and MDA-MB-231 cell lines .
loading...
    loading...